Universal Technical Institute Inc · NYSE:UTI
Universal Technical Institute — Merger or Acquisition (May 2022)
17 slides from Universal Technical Institute's merger presentation, May 4, 2022
Slide 1: Growth & Diversification Strategy Update
Universal Technical Institute Growth & Diversification Strategy Update May 3, 2022 2022 Universal Technical Institute, Inc. All rights reserved. Unless noted otherwise, the contents of this deck are specific to UTI and do not include the pending acquisition of Concorde Career Colleges, Inc. For addi
Slide 2: Forward-Looking Statements
Forward-Looking Statements This document contains statements, estimates, projections or guidance that constitute forward-looking statements as defined under the U.S. federal securities laws about the proposed transaction based on current expectations and assumptions that involve risks and uncertaint
Slide 3: Concorde Acquisition Summary
Concorde Acquisition Summary
Slide 4: UTI to Acquire Concorde Career Colleges
UTI to Acquire Concorde Career Colleges PHOENIX, May 3, 2022 -- Universal Technical Institute, Inc. (NYSE: UTI), a leading provider of transportation and technical training programs, has entered into a definitive agreement to acquire Concorde Career Colleges, Inc. from Liberty Partners LLC. Terms of
Slide 5: Concorde Career Colleges overview
Healthcare education provider focused on preparing America’s next generation of healthcare professionals for rewarding careers in areas such as nursing, dental, patient care, and allied health SUMMARY STATISTICS FOUNDED: 1968 KEY METRICS2: • Composite Score: 1.97 (of 3.00) REVENUE1: ~$180M Adj. EBIT
Slide 6: Significant acquisition adds an established healthcare platform
1 Significant acquisition adds an established Ability to leverage brand in the highly Regulatory metrics and combined scale, attractive healthcare student demographics creating new end-market, expanding meaningfully opportunities for UTI’s role as a leading complement current enhanced growth and wor
Slide 7: Growth and Diversification Strategy Update
Growth and Diversification Strategy Update
Slide 8: UTI Growth and Diversification Strategy Recap
UTI Growth and Diversification Strategy Recap Company’s Management and Board are prudently allocating capital to drive its growth and diversification strategy, while continuing to explore incremental opportunities NEW CAMPUSES Austin, TX and Miramar, FL planned to open in FY 2022, others being evalu
Slide 9: Accelerated Revenue and EBITDA Growth
Bae men Accelerated Revenue ani Wiiiee With the addition of Concorde, expected growth would accelerate versus our prior view leading to estimated FY2025 revenue in excess of $700 million, with estimated adjusted EBITDA margin of ~20% tncines {GraweEL Stoo ‘Substantial gout 5 ——) oe Expanding current
Slide 10: Why Healthcare? Demand for healthcare workers outpaces supply
Ever-increasing demand for healthcare workers continues to far outpace supply, aligning to UTI’s mission as a leading workforce solutions provider for fast-growing fields Growth & Diversification Strategy Alignment: Why Healthcare? Demand Drivers for Healthcare Professionals: ? Healthcare occupation
Slide 11: Strong Demand Healthcare Offerings Enhance Growth Opportunity
Addition of Strong Demand Healthcare Offerings Further Enhances UTI’s Future Growth Opportunity Dental Hygienists & Assistan ts Offerings Healthcare Administration Program Medic al Assistants Nursing 2030 30% - 2020 25% Concorde Physical and Occupational Therapy Assistants Healthcare Programs 20% Ai
Slide 12: Concorde Acquisition Will Accelerate Diversification
The acquisition of Concorde will diversify UTI across key dimensions further reducing seasonality and supporting a steady growth trajectory Revenue by Product Offering Student Demographics UTI UTI + Concorde UTI is currently predominantly 1 igh school grads, military and Based upon 2021 reported res
Slide 13: Disciplined Execution Driving Strategic Growth
Disciplined Execution Driving Strategic Growth With the Concorde announcement, UTI takes another definitive step meaningfully and rapidly advancing its growth & diversification strategy, with incremental future opportunities to drive even further growth and shareholder value Announced Initiatives Fu
Slide 14: Appendix
APPENDIX
Slide 15: Use of Non-GAAP Financial Information
Use of Non-GAAP Financial Information This presentation contains non-GAAP (Generally Accepted Accounting Principles) financial measures, which are intended to supplement, but not substitute for, the most directly comparable GAAP measures. Management chooses to disclose to investors these non-GAAP fi
Slide 16: Adjusted EBITDA Reconciliation
Net income (loss) ~$23,000 $14,581 $8,008 ($7,868) Interest (income) expense, net ~800 282 (1,142) 1,729 Income tax (benefit) expense ~1000 602 (10,602) 203 Depreciation and amortization ~16,500 14,028 13,150 17,291 EBITDA ~$41,300 $29,493 $9,414 $11,355 Acquisition-related costs(1) ~2,300 2,522—-Ne
Slide 17: Wit
Wit
Universal Technical Institute — Merger or Acquisition (May 2022) on 6ix